Univercells, a Belgian technology company that strives to bring a fundamental change to the biomanufacturing industry with the ambition to make biologics (e.g. viral vaccines, monoclonal antibodies, enzyme replacement therapies) available and affordable to all by reinventing bioprocess architecture (technology driven affordability).